Decheng Capital LLC

CIK

2010850

Location

MENLO PARK, CA

Portfolio Value

Small $731,749,065

Diversification

Highly concentrated

Filing Date

Global Rank

#3,070 / 8,795 ▼ 280 · as of Jun 2026

Top Industry

Biotechnology 100.0%

Period ended 3 months ago

Filed Aug 14, 2026 · 54d

11 quarters · since Dec 2023

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

14 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

61.9%

−3.3 pts

Top 5

90.6%

+0.3 pts

Top 10

98.1%

−0.1 pts

HHI

4,272

Highly concentrated−302

Portfolio Trend

11 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$731,749,065	14

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

No qualifying positions this quarter.

Trimmed

Positions the filer reduced

3 positions

Ticker	Company	Δ Shares	Shares	Value
NAMS	NewAmsterdam Pharma Co N.V.	−148,170	176,887	$5,994,700
RVMD	Revolution Medicines, Inc.	−40,833	52,667	$9,863,475
RCUS	Arcus Biosciences, Inc.	−13,040	464,779	$14,329,136
No positions match the current search.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
TNGX	Tango Therapeutics, Inc.	20,000	$625,200
No positions match the current search.

Sold Out

Positions the filer fully exited

1 positions

Ticker	Company	Shares	Value	Open
KRYS	Krystal Biotech, Inc.	7,300	$1,885,736
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

14 tracked positions · $731,749,065 total · filing declares 14 positions · $731,749,074 · as of Jun 30, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
CGON	CG Oncology, Inc. Healthcare	Held	6,371,669	0	$452,707,082	+5.0%	61.87%
NUVB	Nuvation Bio Inc. Healthcare	Held	25,954,439	0	$147,421,213	+32.4%	20.15%
AARD	Aardvark Therapeutics, Inc. Healthcare	Held	3,917,299	0	$22,563,642	+52.8%	3.08%
ACRS	Aclaris Therapeutics, Inc. Healthcare	Held	4,041,736	0	$21,380,783	+41.1%	2.92%
UPB	Upstream Bio, Inc. Healthcare	Held	2,724,868	0	$18,856,086	−23.1%	2.58%
RCUS	Arcus Biosciences, Inc. Healthcare	Reduced	464,779	-13,040	$14,329,136	+38.8%	1.96%
EQ	Equillium, Inc. Healthcare	Held	4,447,308	0	$14,231,385	+60.0%	1.94%
RVMD	Revolution Medicines, Inc. Healthcare	Reduced	52,667	-40,833	$9,863,475	+8.5%	1.35%
LYEL	Lyell Immunopharma, Inc. Healthcare	Held	692,050	0	$9,723,302	−30.0%	1.33%
BYSI	BeyondSpring Inc. Healthcare	Held	3,800,702	0	$6,651,228	+6.7%	0.91%
ZNTL	Zentalis Pharmaceuticals, Inc. Healthcare	Held	1,323,327	0	$6,418,135	+107.3%	0.88%
NAMS	NewAmsterdam Pharma Co N.V. Healthcare	Reduced	176,887	-148,170	$5,994,700	−42.4%	0.82%
PYXS	Pyxis Oncology, Inc. Healthcare	Held	326,810	0	$983,698	+106.2%	0.13%
TNGX	Tango Therapeutics, Inc. Healthcare	NEW	20,000	NEW	$625,200	NEW	0.09%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.